(9-380) Rifaximin Inpatient Utilization for Hepatic Encephalopathy Medication Use Evaluation (MUE)

Wednesday, December 10, 2025

8:30 AM - 9:30 AM

Location: Bayside A, Level 1

Residency Program: HCA Florida Largo Hospital
Residency Program Type: PGY1 (Pharmacy)
Residency Program Location: Florida

Co-Author(s): Monika Ragan

Primary Author(s)

Paola Freyre

PharmD Candidate
Palm Beach Atlantic University, Lloyd L. Gregory School of Pharmacy